Document is current
Any future updates will be listed below
-
Authors
Hiebeler, Miriam
Thiele, Simone
Walter, Maggie C.
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 20 December 2024
First Online: 4 January 2025
Declarations
:
: The patient has consented to participate in the publishing of her case. Ethics approval was not necessary.
: The patient has given written informed consent to the publication of her case including personal and clinical details and possible images.
: Miriam Hiebeler received Speaker Honoraria from Biogen. Maggie C. Walter has served on advisory boards for Avexis, Biogen, Novartis, Pfizer, Roche, Santhera, Sarepta, Pharnext, PTC Therapeutics, Ultragenyx, Wave Sciences, received funding for Travel or Speaker Honoraria from Avexis, Biogen, PTC Therapeutics, Ultragenyx, Santhera, Sarepta, and worked as an ad-hoc consultant for AskBio, Audentes Therapeutics, Avexis, Biogen Pharma GmbH, Fulcrum Therapeutics, GLG Consult, Guidepoint Global, Gruenenthal Pharma, Novartis, Pharnext, PTC Therapeutics, Roche. Simone Thiele has no conflicts to report.
